Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient

Kimberly N Hong1, Alexander Iribarne, Berhane Worku

  • 1Division of Cardiothoracic Surgery, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Insights

A new risk stratification score (RSS) helps predict 1-year graft failure after heart transplantation. This score identifies patients at high risk, improving organ allocation and patient outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Statistics

Background:

  • Pretransplant recipient and donor characteristics significantly impact heart transplant outcomes.
  • Objective assessment of these factors is crucial for predicting graft survival.
  • Developing a reliable risk score can aid in clinical decision-making.

Purpose of the Study:

  • To objectively assess risks associated with pretransplant characteristics in heart transplant recipients.
  • To develop a preoperative risk stratification score (RSS) for predicting 1-year graft loss.
  • To define distinct risk strata based on the developed RSS.

Main Methods:

  • Analysis of 11,703 heart transplant recipients from the United Network for Organ Sharing (2001-2007).
  • Multivariable logistic regression to identify predictors of 1-year graft failure.
  • Development of an RSS using odds ratios and defining strata via receiver operating characteristic curves.

Main Results:

  • Key predictors of graft failure include prior mechanical support (RVAD, ECMO, LVAD, TAH), renal failure, and advanced age.
  • Five RSS strata were identified: Low (27.7%), Intermediate (54.2%), Moderate (13.2%), Elevated (2.6%), and High Risk (2.2%).
  • 1-year survival rates decreased significantly with increasing RSS strata, from 93.8% (Low) to 47.0% (High).

Conclusions:

  • Pretransplant recipient factors are significant predictors of early and late graft failure.
  • The developed RSS can enhance organ allocation strategies.
  • Utilizing the RSS may mitigate negative outcomes in high-risk heart transplant candidates.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...